Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 5.9B | 5.6B | 5.4B |
Cost of revenue | 3.6B | 3.6B | 3.4B | 3.3B |
Gross profit | 2.4B | 2.3B | 2.2B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 668M | 733M | 514M | 485M |
Other operating expenses | — | — | — | — |
Operating income | 1.0B | 941M | 1.1B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 232M | 201M | 131M | 136M |
Other income expense | -8M | -40M | -1M | -37M |
Pretax income | 788M | 700M | 995M | 894M |
Tax provision | 151M | 102M | 235M | 214M |
Net income | 637M | 598M | 760M | 680M |
Basic EPS | 0.8 | 0.7 | 0.9 | 0.9 |
Diluted EPS | 0.8 | 0.7 | 0.9 | 0.8 |
Basic average shares | 141.7M | 141.4M | 141.4M | 141.3M |
Diluted average shares | 142.2M | 142.1M | 142.0M | 142.0M |
EBITDA | 1.7B | 1.6B | 1.7B | 1.6B |
Net income from continuing op. | 637M | 598M | 760M | 680M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |